Cancer is one of the first mortality cause in the world

ONCOLOGY

Each year, cancer is responsible for nearly 10 million deaths worldwide. In France, an estimated 433,136 new cancer cases were diagnosed in 2023. Cancer caused 162,400 deaths in 2021, affecting 90,900 men and 71,500 women.

Cancer treatment has significantly improved in recent years, but it remains one of the leading sources of healthcare expenditures in developed countries. In the United States, annual cancer-related healthcare costs were estimated at $190.2 billion in 2015 and were projected to reach $208.9 billion in 2020.

These figures highlight the importance of innovation and efficiency in medical devices designed for cancer treatment. By offering advanced solutions tailored to the needs of both patients and healthcare professionals, we help improve the quality of care while optimizing medical resources.

BECOME A DISTRIBUTOR DOWNLOAD CATALOG

Cardiovascular Diseases: A Global Health Challenge

VASCULAR

Cardiovascular diseases remain the leading cause of mortality worldwide, with 18.6 million deaths per year in 2023, accounting for approximately one-third of global deaths. In the United States, more than 120 million people were affected by a cardiovascular condition in 2022, representing nearly 40% of the population.

The economic impact is staggering in 2023, the average annual per capita expenditure for cardiovascular disease treatment was €500 in Germany, €400 in the United Kingdom, and €250 in France. These costs continue to rise due to population aging, increasingly sedentary lifestyles, and the growing complexity of medical technologies.

Given this reality, prevention and medical innovation are more crucial than ever to reduce the incidence of cardiovascular diseases and their impact on our societies.

BECOME A DISTRIBUTOR DOWNLOAD CATALOG

NEUROSURGERY

Neurological disorders are among the most pressing public health challenges of our time. In France, 122,422 adults were hospitalized for stroke in 2022, with 30,682 deaths recorded. Across Europe, brain disorders (including neurological and psychiatric conditions) cost more than €800 billion annually.

Globally, the direct healthcare cost of brain disorders reached around USD 1.7 trillion in 2019. In 2016, neurological conditions accounted for approximately 276 million DALYs and 9 million deaths worldwide.

These figures highlight the urgent need for innovation in neurosurgery. ISOMED is developing a new line of devices designed to enhance surgical precision, reduce risks, and support faster recovery. Our goal is to empower neurosurgeons and improve outcomes for millions of patients worldwide.

BECOME A DISTRIBUTOR DOWNLOAD CATALOG